Secondary Acute Myelogenous Leukemia in Patients with Retinoblastoma. Is Chemotherapy a Factor?

Ophthalmology

Volumn 114, Issue 7, 2007, Pages 1378-1383

  Gombos, Dan S ^a   Hungerford, John ^b,c   Abramson, David H ^d   Kingston, Judith ^b   Chantada, Guillermo ^e   Dunkel, Ira J ^d   Antoneli, Celia B G ^f   Greenwald, Mark ^g   Haik, Barret G ^h   Leal, Carlos A ⁱ   Medina Sanson, Aurora ^j   Schefler, Amy C ^k   Veerakul, Gavivann ^l   Wieland, Regina ^m   Bornfeld, Norbert ^m   Wilson, Mathew W ^h   Yu, Christopher Bing On ⁿ  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e Hospital JP Garrhan   (Argentina)

^f FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^g UNIVERSITY OF CHICAGO   (United States)

^h UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

ⁱ Pediatric National Institute   (Mexico)

^j HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^k UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^l MAHIDOL UNIVERSITY   (Thailand)

^m UNIVERSITY OF DUISBURG ESSEN   (Germany)

ⁿ CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DOXORUBICIN; EPIPODOPHYLLOTOXIN; ETOPOSIDE; GYRASE INHIBITOR; IDARUBICIN; IFOSFAMIDE; METHOTREXATE; TENIPOSIDE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; AGE DISTRIBUTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOTHERAPY; DATA BASE; DISEASE ASSOCIATION; EUROPE; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; INFANT; LEUKEMIA; MALE; MULTIPLE CYCLE TREATMENT; NEWBORN; PATIENT REFERRAL; PRIORITY JOURNAL; RETINOBLASTOMA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHILD, PRESCHOOL; COHORT STUDIES; DATABASES, FACTUAL; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; NEOPLASMS, SECOND PRIMARY; PODOPHYLLOTOXIN; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 34347342867     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.03.074     Document Type: Article

References (42)

1. Murphree A.L., Villablanca J.G., Deegan III W.F., et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 114 (1996) 1348-1356
2. Kingston J.E., Hungerford J.L., Madreperlqa S.A., and Plowman P.N. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 114 (1996) 1339-1343
3. Shields C.L., De Potter P., Himelstein B.P., et al. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 114 (1996) 1330-1338
4. Shields C.L., Shields J.A., Needle M., et al. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology 104 (1997) 2101-2111
5. Gombos D.S., Kelly A., Coen P.G., et al. Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location and age. Br J Ophthalmol 86 (2002) 80-83
6. Lumbroso L., Doz F., Urbieta M., et al. Chemothermotherapy in the management of retinoblastoma. Ophthalmology 109 (2002) 1130-1136
7. Schueler A.O., Jurklies C., Heimann H., et al. Thermochemotherapy in hereditary retinoblastoma. Br J Ophthalmol 87 (2003) 90-95
8. Deegan W.F. Emerging strategies for the treatment of retinoblastoma. Curr Opin Ophthalmol 14 (2003) 291-295
9. Abramson D.H., Ellsworth R.M., Kitchin F.D., and Tung G. Second nonocular tumors in retinoblastoma survivors: are they radiation-induced?. Ophthalmology 91 (1984) 1351-1355
10. Abramson D.H., Melson M.R., Dunkel I.J., and Frank C.M. Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma. Ophthalmology 108 (2001) 1868-1876
11. Abramson D.H., and Frank C.M. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology 105 (1998) 573-579
12. Moll A.C., Imhof S.M., Schouten-Van Meeteren A.Y., et al. Second primary tumors in hereditary retinoblastoma: a register-based study, 1945-1997. Is there an age effect on radiation-related risk?. Ophthalmology 108 (2001) 1109-1114
13. Eng C., Li F.P., Abramson D.H., et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 85 (1993) 1121-1128
14. Kleinerman R.A., Tucker M.A., Tarone R.E., et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 23 (2005) 2272-2279
15. Gallegos-Castorena S., Medina-Sanson A., Gonzalez-Montalvo P., et al. Acute myeloid leukemia in a patient surviving retinoblastoma. [letter]. Med Pediatr Oncol 38 (2002) 450
16. Nishimura S., Sato T., Ueda H., and Ueda K. Acute myeloblastic leukemia as a second malignancy in a patient with hereditary retinoblastoma. [letter]. J Clin Oncol 19 (2001) 4182-4183
17. Felice M.S., Zubizarreta P.A., Chantada G.L., et al. Acute myeloid leukemia as a second malignancy: report of 9 pediatric patients in a single institution in Argentina. Med Pediatr Oncol 30 (1998) 160-164
18. Draper G.J., Sanders B.M., and Kingston J.E. Second primary neoplasms in patients with retinoblastoma. Br J Cancer 53 (1986) 661-671
19. White L., Ortega J.A., and Ying K.L. Acute non-lymphocytic leukemia following multimodality therapy for retinoblastoma. Cancer 55 (1985) 496-498
20. Gibbons B., Scott D., Hungerford J.L., et al. Retinoblastoma in association with the chromosome breakage syndromes Fanconi's anaemia and Bloom's syndrome: clinical and cytogenetic findings. Clin Genet 47 (1995) 311-317
21. Antoneli C.B., de Almeida M.P., Erwenne C.M., et al. Secondary acute myeloid leukemia after therapy for extraocular retinoblastoma: a case report. South Am J Cancer 2 (1998) 65-68
22. Dunkel I.J., Chantada G.L., Fandino A.C., and Abramson D.H. Lack of activity of oral etoposide for relapsed intraocular retinoblastoma. Ophthalmic Genet 25 (2004) 25-29
23. Shields C.L., Meadows A.T., Shields J.A., et al. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol 119 (2001) 1269-1272
24. Travis L.B., Holowaty E.J., Bergfeldt K., et al. Risk of leukemia after platinum-based chemotherapy for ovarian cancer. N Engl J Med 340 (1999) 351-357
25. Kollmannsberger C., Hartmann J.T., Kanz L., and Bokemeyer C. Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies. J Cancer Res Clin Oncol 124 (1998) 207-214
26. Matesich S.M., and Shapiro C.L. Second cancers after breast cancer treatment. Semin Oncol 30 (2003) 740-748
27. Smith R.E., Bryant J., DeCillis A., and Anderson S. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project experience. J Clin Oncol 21 (2003) 1195-1204
28. Smith R.E. Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project experience. Clin Breast Cancer 4 (2003) 273-279
29. Pedersen-Bjergaard J., Daugaard G., Hansen S.W., et al. Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin and bleomycin for germ-cell tumours. Lancet 338 (1991) 359-363
30. Felix C.A. Leukemias related to treatment with DNA topoisomerase II inhibitors. Med Pediatr Oncol 36 (2001) 525-535
31. Kollmannsberger C., Beyer J., Droz J.P., et al. Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors. J Clin Oncol 16 (1998) 3386-3391
32. Davies S.M. Therapy-related leukemia associated with alkylating agents. Med Pediatr Oncol 36 (2001) 536-540
33. Winick N.J., McKenna R.W., Shuster J.J., et al. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol 11 (1993) 209-217
34. Smith M.A., Rubinstein L., and Ungerleider R.S. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks. Med Pediatr Oncol 23 (1994) 86-98
35. Smith M.A., McCaffrey R.P., and Karp J.E. The secondary leukemias: challenges and research directions. J Natl Cancer Inst 88 (1996) 407-418
36. Pui C.H., Ribeiro R.C., Hancock M.L., et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 325 (1991) 1682-1687
37. Smith M.A., Rubinstein L., Anderson J.R., et al. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol 17 (1999) 569-577
38. Sauerbrey A., Stammler G., Zintl F., and Volm M. Expression of the retinoblastoma tumor suppressor gene (RBrb-1) in acute leukemia. Leuk Lymphoma 28 (1998) 275-283
39. La Starza R., Wlodarska I., Aventin A., et al. Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies. Blood 91 (1998) 231-237
40. Ahuja A.G., Jat P.S., Foti A., et al. Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Blood 78 (1991) 3259-3268
41. Jamal R., Gale R.E., Shaun N., et al. The retinoblastoma gene (rb1) in acute myeloid leukaemia: analysis of gene rearrangements, protein expression and comparison of diseases outcome. Br J Haematol 94 (1996) 342-351
42. Wong F.L., Boice Jr. J.D., Abramson D.H., et al. Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. JAMA 278 (1997) 1262-1267